Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020		Sep. 30, 2019
Revenue
Revenue	$ 18,765	$ 18,604	$ 54,530		$ 58,865
Cost of Revenue:
Total cost of revenue	7,519	7,364	22,033		26,348
Gross Profit	11,246	11,240	32,497		32,517
Operating Expenses
Selling, general and administrative	12,442	13,708	36,864		42,843
Research and development	4,681	3,262	12,446		10,503
Amortization of acquisition-related assets	958	1,054	2,691		3,162
Impairment of intangible asset	0	0	0		3,977
Total operating expenses	18,081	18,024	52,001		60,485
Loss from operations	(6,835)	(6,784)	(19,504)		(27,968)
Interest expense, net	(4,861)	(4,556)	(14,291)		(13,443)
Other income (expense), net	747	(3,586)	(2,550)		(5,022)
Loss from related party equity method investment	0	(1,983)	(31,702)	[1]	(6,401)	[1]
Loss from continuing operations before income taxes	(10,949)	(16,909)	(68,047)		(52,834)
Provision for (benefit from) income taxes	77	(529)	174		(659)
Net loss from continuing operations	(11,026)	(16,380)	(68,221)		(52,175)
(Loss) income from discontinued operations, net of tax attributable to NantHealth	(16)	3	31,955		1,162
Net loss	(11,042)	(16,377)	(36,266)		(51,013)
Net loss attributable to noncontrolling interests	(42)	0	(42)		0
Net loss attributable to NantHealth	$ (11,000)	$ (16,377)	$ (36,224)		$ (51,013)	[1]
Basic and diluted net income (loss) per share attributable to NantHealth:
Continuing operations - common stock (in dollars per share)	$ (0.10)	$ (0.15)	$ (0.62)		$ (0.47)
Discontinued operations - common stock (in dollars per share)	0	0	0.29		0.01
Total net income (loss) per share - common stock (in dollars per share)	$ (0.10)	$ (0.15)	$ (0.33)		$ (0.46)
Weighted average shares outstanding
Basic and diluted - common stock (shares)	110,929,357	110,619,905	110,859,611		110,261,279
Total software-related revenue
Revenue
Revenue	$ 18,716	$ 18,328	$ 54,358		$ 54,421
Cost of Revenue:
Total cost of revenue	7,303	6,902	21,206		20,811
Software-as-a-service related
Revenue
Revenue	18,355	18,328	53,997		54,421
Cost of Revenue:
Total cost of revenue	5,935	5,638	17,552		17,004
Maintenance
Revenue
Revenue	299	0	299		0
Cost of Revenue:
Total cost of revenue	131	121	131		288
Professional services
Revenue
Revenue	62	0	62		0
Cost of Revenue:
Total cost of revenue	15	0	15		0
Amortization of developed technologies
Cost of Revenue:
Total cost of revenue	1,222	1,143	3,508		3,519
Sequencing and molecular analysis
Revenue
Revenue	49	276	172		1,581
Cost of Revenue:
Total cost of revenue	216	462	827		4,066
Home health care services
Revenue
Revenue	0	0	0		2,863
Cost of Revenue:
Total cost of revenue	$ 0	$ 0	$ 0		$ 1,471

[1] The statements for the nine months ended September 30, 2020 and 2019 include the Connected Care Business (see Note 4).